The investigation of this miRNA panel allows the evaluation of internal tumor physiology, indicating the change towards a more invasive phenotype by downregulation of tumor suppressor miRNA, upregulation of oncomiRs, inhibition of tumor suppressor genes, such as TP53, and activation of EMT. The gene discussed is TP53; the disease is neoplasm.